Seeking Alpha

  Novo Nordisk A/S (NVO) - NYSE

  • Jim Van Meerten | Send Message 1 Feb 2013

    $NVO - 100% Barchart technical buy signal - 19 new highs and up 16.79% in the last month - Relative Strength Index 80.13%
      NVO vs. ETF Alternatives
      Company Description
      Novo-Nordisk A/S is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company has two business segments: diabetes care and biopharmaceuticals.
      Sector: Healthcare
      Country: Denmark